Effect of the Antiparasitic Drug Mebendazole on Cholangiocarcinoma Growth.

Abstract

Mebendazole (MBZ) is an anthelmintic drug which inhibits tubulin polymerization and eventually causes apoptosis in target organisms. Antitumor activity of MBZ has been reported in various cancers. The aim of this study was to investigate the effect of MBZ on cholangiocarcinoma (CCA) cells in vitro and in vivo. MBZ reduced cell proliferation in the KKU-M213… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.